Creative Planning’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-19,900
| Closed | -$101K | – | 1982 |
|
|
2019
Q3 | $101K | Hold |
19,900
| – | – | ﹤0.01% | 1705 |
|
|
2019
Q2 | $123K | Buy |
19,900
+2,000
| +11% | +$12.4K | ﹤0.01% | 1710 |
|
|
2019
Q1 | $83K | Hold |
17,900
| – | – | ﹤0.01% | 1707 |
|
|
2018
Q4 | $75K | Sell |
17,900
-240,700
| -93% | -$1.01M | ﹤0.01% | 1652 |
|
|
2018
Q3 | $1.62M | Buy |
258,600
+49,890
| +24% | +$313K | 0.01% | 542 |
|
|
2018
Q2 | $1.68M | Buy |
208,710
+50,310
| +32% | +$404K | 0.01% | 519 |
|
|
2018
Q1 | $1.18M | Buy |
158,400
+16,600
| +12% | +$124K | ﹤0.01% | 646 |
|
|
2017
Q4 | $844K | Buy |
141,800
+38,400
| +37% | +$229K | ﹤0.01% | 813 |
|
|
2017
Q3 | $761K | Buy |
103,400
+100,500
| +3,466% | +$740K | ﹤0.01% | 829 |
|
|
2017
Q2 | $20K | Sell |
2,900
-9,350
| -76% | -$64.5K | ﹤0.01% | 3164 |
|
|
2017
Q1 | $116K | Sell |
12,250
-2,950
| -19% | -$27.9K | ﹤0.01% | 1843 |
|
|
2016
Q4 | $131K | Sell |
15,200
-57,800
| -79% | -$498K | ﹤0.01% | 1672 |
|
|
2016
Q3 | $462K | Buy |
73,000
+70,000
| +2,333% | +$443K | ﹤0.01% | 930 |
|
|
2016
Q2 | $13K | Hold |
3,000
| – | – | ﹤0.01% | 3058 |
|
|
2016
Q1 | $13K | Sell |
3,000
-200
| -6% | -$867 | ﹤0.01% | 3047 |
|
|
2015
Q4 | $20K | Buy |
+3,200
| New | +$20K | ﹤0.01% | 2826 |
|
|
2014
Q3 | – | Sell |
-1,500
| Closed | -$6K | – | 4052 |
|
|
2014
Q2 | $6K | Hold |
1,500
| – | – | ﹤0.01% | 3071 |
|
|
2014
Q1 | $6K | Buy |
+1,500
| New | +$6K | ﹤0.01% | 2959 |
|